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Background: Polar overdominance at the ovine callipyge (CLPG) locus involves the post-transcriptional trans-inhibition
of DLK1 in skeletal muscle of CLPG/CLPG sheep. The abundant maternally expressed microRNAs (miRNAs) mapping to
the imprinted DLK1-GTL2 domain are prime candidate mediators of this trans-effect.
Results: We have tested the affinity of 121 miRNAs processed from this locus for DLK1 by co-transfecting COS1 cells
with a vector expressing the full-length ovine DLK1 with corresponding mimic miRNAs. None of the tested miRNAs
was able to down regulate DLK1 to the extent observed in vivo.
Conclusions: This suggests that other factors, with or without these miRNAs, are involved in mediating the observed
trans-effect.
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The callipyge phenotype is a muscular hypertrophy that is
exclusively expressed by heterozygous sheep inheriting the
CLPG mutation from their sire (genotype +Mat/CLPGPat).
This non-Mendelian mode of inheritance with parent-of-
origin effect is referred to as polar overdominance [1,2].
The underlying increase in the proportion and size of fast
twitch muscle fibers is thought to be caused by ectopic ex-
pression of DLK1 and/or PEG11 (also known as RTL1)
protein in skeletal muscle of + Mat/CLPGPat animals. This
ectopic expression results from the inactivation – by the
CLPG A to G point mutation – of a muscle-specific silen-
cer element that post-natally downregulates the expression
of DLK1 and PEG11 in cis [3-6]. CLPGMat/+Pat animals do
not express the phenotype because DLK1 and PEG11
genes are imprinted and only expressed from the paternal
allele. It is thought that CLPG/CLPG animals do not
express the phenotype because of the additional ectopic* Correspondence: htakeda@ulg.ac.be
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unless otherwise stated.expression of non-coding RNAs (ncRNAs) that are (i)
imprinted and expressed from the maternal allele, (ii) con-
trolled in cis by the same muscle-specific silencer element,
and (iii) post-transcriptionally down-regulating DLK1 and
PEG11 in trans [7]. Maternally expressed ncRNA genes in
the CLPG locus include four long ncRNAs (lncRNA)
(GTL2, anti-PEG11, RIAN and MIRG) as well as 110 and
47 embedded miRNAs and C/D snoRNAs, respectively
[8-10]. For PEG11 the trans-inhibition results from RNA-
induced silencing complex (RISC)-mediated cleavage of
PEG11 transcripts by at least three perfectly complemen-
tary miRNAs processed from the maternally expressed
anti-PEG11 lncRNA [11]. For DLK1, the mechanism of
the trans-inhibition remains unknown. The present
working model for the callipyge phenomenology is sum-
marized in Additional file 1: Figure S1.
When compared to + Mat/CLPGPat animals, DLK1
levels in CLPG/CLPG animals are more severely reduced
at the protein (~10-fold) than at the mRNA (~3-fold)
level [5,12,13]. This pattern is compatible with a
miRNA-mediated effect that would affect mRNA stabil-
ity and translation. It made the abundant miRNAs fromLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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the observed trans-inhibition. However, bioinformatic
analyses did not reveal a striking affinity of any of these
miRNAs for DLK1. At best, there was some evidence
suggesting that they might have an unusual affinity for
the open reading frame (ORF) of DLK1 when assumed
to act jointly as a team [10]. As bioinformatic target pre-
dictions reputably have limited sensitivity and specificity,
we wanted to experimentally evaluate the effect of the
miRNAs from the DLK1-GTL2 domain on ovine DLK1.
Results
Given the prior evidence that (i) the miRNA from the
DLK1-GTL2 domain might target the ORF of DLK1 ra-
ther than its 3’ untranslated region (UTR) [10], and (ii)
that their effect might be more pronounced on protein
than mRNA concentrations [5], we decided to develop a
reporter assay that would (i) express full-length ovine
DLK1 transcripts including 5’ UTR, ORF and 3’ UTR,
and (ii) assay protein rather than mRNA levels. We first
performed 5’ and 3’ rapid amplification of cDNA ends
(RACE) experiments using RNA from sheep skeletal
muscle to accurately map the predominant transcription
start and poly-adenylation sites of DLK1 (see Additional
file 1: Figure S2). We then assembled a 1,405-bp frag-
ment corresponding to 209-bp of ovine upstream se-
quence (encompassing the transcription start site
mapped 174-bp upstream of the ATG start codon), 954-
bp of ORF corresponding to the ovine DLK1 C2 isoform
appended with a 9-residue human influenza haemagglu-
tinin (HA) carboxyterminal tag, and 242-bp of down-
stream sequences including an XhoI restriction site
(6-bp) and the 236-bp ovine DLK1 3’ UTR (ending
exactly at the position of the ovine poly-adenylation site)
(see Additional file 1: Figure S3A; Additional file 1: Text
S1). We selected the C2 isoform of DLK1 as (i) it is at
least 100 times more abundant than the A isoform in
ovine skeletal muscle between -2 and +8 weeks relative
to birth, and (ii) the ratio of the transcript levels of the
C2 and A isoforms is not affected by CLPG genotype
(implying that both isoforms encompass the determi-
nants required for the trans-effect)[5,14]. The HA tag
was introduced because available anti-human DLK1
antibodies did not effectively recognize ovine DLK1
(data not shown). The corresponding fragment was
cloned in a slightly modified pcDNA3.1(-) vector, 1-bp
downstream of the vector-specific transcriptional start
site and 30-bp upstream of the vector-specific bovine
growth hormone polyadenylation site. The resulting con-
struct (p3.1M-DLK1-HA) was completely sequenced to
confirm its integrity. It was shown, upon transfection in
COS1 cells, (i) to generate a transcript of expected size
(~1.4-kb) (Northern blotting), (ii) bounded by the
vector-specific transcription start and polyadenylationsites (and hence appended with 1-base of upstream and
30-bases of downstream vector-specific sequences) (5’
and 3’ RACE), and (iii) producing a protein of expected
size recognized by anti-HA antibodies (~34 kDa after
deglycosylation, Western blotting) (see Additional file 1:
Figure S3). Within the examined range, DLK1 amounts
estimated by phosphorimaging and densitometry in-
creased linearly with loaded quantities (r2 = 0.98) (see
Additional file 1: Figure S4).
We designed 121 mimic miRNAs, corresponding to
one or two isomirs for 108 of the 110 miRNA species
from the DLK1-GTL2 domain detected in ovine muscle
[10] (see Additional file 2: Table S1 and Methods). In
addition, we designed one perfectly complementary anti-
DLK1 siRNA as positive control and two miRNAs,
corresponding to scrambled miR-127 and miR-377, as
negative controls (hereafter referred to as siRNA, NC1,
and NC2, respectively).
We transfected COS1 cells with a mixture of DLK1-
expressing p3.1M-DLK1-HA vector, GFP-expressing
pcDNA3-GFP vector (to evaluate and correct for vari-
ation in transfection efficiency and gel-loaded protein
amount), and individual mimic miRNA (Figure 1A). We
performed ≥4 independent transfections for each miRNA,
and ran ≥2 independent Western blot experiments per
transfection, yielding an average of 8.3 usable measures
per miRNA. DLK1 amounts, estimated by densitometry,
were normalized to GFP amounts as detailed in Methods
(see Additional file 1: Figure S5).
As expected (because of its perfect complementarity
and predicted cleavage activity), the siRNA positive con-
trol exhibited a strong inhibitory effect. It behaved as a
complete outlier, reducing the amount of DLK1 ~ 3-fold
when compared to the average of the two negative con-
trols, and this effect was highly significant (p = 2 × 10−16)
(Figure 1B and see Additional file 2: Table S2). Seven of
the 121 tested miRNAs significantly (p ≤0.05/121 = 4 ×
10−4) altered DLK1 levels when compared to the average
of the negative controls. One of these caused a reduction
in DLK1 levels (miR-329a-3p, 1.25-fold reduction, p =
3.8 × 10−4), while the remaining six increased amounts of
DLK1 (≤1.28-fold increase, p ≥1 × 10−8). Overall, the 121
miRNAs and the two negative controls appeared to be-
long to one population (Figure 1B). Accordingly, when
compared to the average of all miRNAs (except for the
siRNA), one miRNA significantly decreased DLK1 levels
(miR-329a-3p, 1.31-fold reduction, p = 3.2 × 10−5), and
two significantly increased DLK1 levels (miR-376a-5p,
1.25-fold increase, p = 5 × 10−7; miR-432-3p, 1.18-fold
increase, p = 1.8 × 10−5). MiR-329b-3p, which differs
from miR-329a-3p at only two residues near the 3’ end,
reduced DLK1 amounts 1.1-fold when compared to the
overall average, but this was not significant when ac-
counting for multiple testing (p = 0.047). MiR-329a-3p
Figure 1 Experimental evaluation of the effect of microRNA from the callipyge locus on DLK1 expression. (A) Overview of experimental
procedure of ovine DLK1 reporter assay. We co-transfected COS1 cells with a mixture of ovine full-length (5’ UTR, ORF, and 3’ UTR)
DLK1-expressing vector (p3.1M-DLK1-HA), GFP-expressing vector (pcDNA3-GFP) for normalizing transfection efficiency and gel-loaded protein
amount, and one of 121 mimic miRNA candidates from the DLK1-GTL2 imprinted domain, two negative controls (NC1, NC2), and one siRNA
targeting the DLK1 ORF as positive control. To facilitate protein quantification, an HA epitope was engineered at the carboxyterminal end of
DLK1. Amounts of DLK1, GFP, and endogenous Tubulin were estimated by dual fluorescent Western blot (WB). Effect of each miRNA on DLK1
translation was estimated by normalizing DLK1 with either GFP or Tubulin amounts (corrected DLK1 amount). (B) Distribution of effects of the
121 mimic miRNAs on DLK1 protein amounts. Effects are expressed as fold difference with respect to the overall (minus siRNA) mean. The effects
of two negative (NC1, NC2) and one positive (siRNA) controls are shown, as are the effects of the most inhibiting miR-329a-3p, the closely related
miR-329b-3p, and the most activating miR-376a-5p and miR-432-3p. GFP was used for normalization. (C) Evaluation of synergistic action of
multiple miRNA on DLK1 amount. We selected seven miRNAs consistently showing inhibiting, activating, and neutral effects on DLK1 amount.
COS1 cells were co-transfected with the p3.1M-DLK1-HA and pcDNA3-GFP vectors along with either a mixture of the seven miRNAs (mix), or a
single miRNA having shown the lowest (1st) or highest (last) corrected DLK1 amount upon transfection in each group. DLK1-HA and GFP protein
levels were estimated by dual fluorescent WB analysis (upper panel). Means of corrected DLK1 amounts with standard deviations for four
independent experiments are shown (lower panel).
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and one in the 3’ UTR. However, neither of these is evo-
lutionary conserved (see Additional file 1: Figure S6).
miR-329a-3p and miR-329b-3p accounted respectively
for 0.0014% and 0.19% of miRNA molecules derived from
the DLK1-GTL2 domain and 0.00043% and 0.056% of
total miRNA molecules in skeletal muscle of CLPG/
CLPG animals [10]. It is also noteworthy that we did not
observe a convincing correlation between effect on DLK1
levels and bioinformatically predicted affinity for DLK1,
whether using seed-based scores [15] or Miranda [16],
and whether considering the 3’ UTR, the ORF, the 5’
UTR or the full-length DLK1 transcript (see Additional
file 1: Figure S7; Additional file 2: Table S2).Taken together, these data suggest that none of the
tested miRNAs effectively regulates DLK1. Although the
effect of miR-329a-3p is significant, we consider the evi-
dence insufficient to claim that it is biologically relevant.
Indeed, (i) the effects of the 121 tested miRNAs are ap-
proximately normally distributed, encompass the effects
of the two negative controls, and are not correlated with
predicted affinity for DLK1, (ii) there are more miRNAs
that have a significant positive effect than miRNAs that
have a negative effect on DLK1 expression (which is un-
likely to reflect a genuine biological activity given the
known modus operandi of miRNAs), (iii) the effect of
miR-329a-3p becomes insignificant when considered
jointly with the closely related miR-329b-3p, (iv) the
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is extremely low. What is certain is that none of the
tested miRNAs is capable – under the utilized condi-
tions - to single-handedly downregulate DLK1 to the
extent that is observed in vivo in skeletal muscle of
CLPG/CLPG sheep.
It remains possible that the observed trans-inhibition
of DLK1 results from the synergistic action of multiple
miRNAs. Although we could obviously not test all com-
binations of miRNAs, we transfected COS1 cells with
pools of seven miRNAs chosen (i) amongst the most
inhibiting, and (ii) most activating miRNAs. The pools
of extremes inhibited, respectively enhanced, DLK1
expression to a degree similar to their constituent
miRNAs, but did not reveal convincing evidence for a
synergistic effect (Figure 1C and see Additional file 1:
Figure S8).
Discussion
The aim of this study was to experimentally verify
whether any of the miRNAs processed from the ovine
DLK1-GTL2 domain might post-transcriptionally down-
regulate DLK1 to a degree that is commensurate with
what is observed in skeletal muscle of CLPG/CLPG
sheep. Although one miRNA (miR-329a-3p) yielded an
effect deemed significant even when accounting for mul-
tiple testing, it was not considered to be relevant with
regards to the trans-inhibition of DLK1 in CLPG/CLPG
animals for the reasons given above. Of note, when
performing ANOVA analysis the “miRNA effect” (not
including the three controls) was highly significant
(p <2 × 10−16). Thus, the effects of at least some
miRNAs are repeatable despite being modest. This could
reflect subtle effects on DLK1, on GFP, or on the cellular
machinery.
Negative results are in essence uncomfortable to inter-
pret. They may be false negatives because the established
reporter assay misses an essential component that is re-
quired for the responsible miRNAs to exert their effect.
MiRNA-mediated regulation of DLK1 may require auxil-
iary trans-acting factors not expressed in COS1 cells.
The expressed transcripts corresponded for >93% to the
ovine DLK1 C2 mRNA, yet included 36-bases of extra
upstream, 33-bases of extra internal (HA tag), and 30-
bases of extra downstream sequence, and these may have
affected miRNA-target interactions. To discriminate
between a miRNA-dependent versus independent mech-
anism, we have conducted immuno-precipitation experi-
ments using antibodies directed against the Argonaut
components of the RISC [17], hoping to show an increase
in DLK1 co-immunoprecipitation in skeletal muscle of
CLPG/CLPG when compared to +Mat/CLPGPat animals,
but have so far failed to obtain convincing results (data
not shown).Alternatively, our results may be true negatives and in-
dicate that the trans-inhibition of DLK1 observed in vivo
is not a post-transcriptional regulation mediated directly
by miRNAs processed from the DLK1-GTL2 domain. It
is worthwhile noting in this regard that, while the larger
effect on DLK1 protein than on DLK1 transcripts is
reminiscent of early reports of the modus operandi of
the archetypical animal miRNA lin-4 on its lin-28 and
lin-14 targets in C. elegans, lin-4’s mode of action has
since been revisited and shown to be more in line with
the canonical one in which mRNA destabilization ac-
counts for the major component of repression [18,19].
Moreover, the ~3-fold and ~10-fold down-regulation of
DLK1 observed respectively at the mRNA and protein
levels in vivo would be rather extreme for miRNA-
dependent effects [20,21]. Alternative hypotheses include
a direct post-transcriptional effect of one or several of
the maternally expressed lncRNAs, or an indirect post-
transcriptional effect of anyone of the ncRNAs from the
domain. As for most lncRNAs, little is known about the
function of the maternally expressed GTL2, RIAN and
MIRG genes. It has been suggested that GTL2 recruits
Polycomb Repressive Complex 2 (PRC2) to down-
regulate the reciprocally imprinted DLK1 gene in cis
[22]. Preliminary results of the co-transfection of COS1
cells with p3.1M-DLK1-HA with a vector expressing the
predominant isoform of ovine GTL2 (corresponding to
human GTL2 variant 1, NR_002766.2) does not support
a direct inhibitory trans-effect of GTL2 on DLK1 expres-
sion, on the contrary (see Additional file 1: Figure S9).
The hypothesis of an indirect effect posits that the
maternally expressed ncRNAs affect targets that do not
originate from the DLK1-GTL2 locus, and that these in
turn affect DLK1 expression. Such indirect effects may
manifest themselves by changes in transcript levels that
could be studied by comparing the transcriptome (in-
cluding small RNAs) of CLPGMat/+Pat with that of +/+
animals, and efforts towards that goal are in progress.
Along similar lines, Bidwell et al. [23] recently showed
that muscle of CLPG/CLPG animals exhibited lower
expression of a group of key regulatory genes for muscle
development (e.g. ZFP106, RPS6KA3, MEF2A), that
might render them less responsive to the hypertrophic
stimuli of the paternal allele-specific genes.
The apparently stronger effect on DLK1 protein (~10-
fold) than on DLK1 transcript (~3-fold) level suggests
a post-transcriptional mechanism. This hypothesis re-
ceived considerable support from the demonstration of
the RISC-mediated cleavage of PEG11 by miRNAs proc-
essed from anti-PEG11 [11]. However, we cannot totally
exclude a transcriptional mechanism. It may be worth-
while, in this regard, to perform ribosome profiling [24]
experiments to verify whether the predicted translational
inhibition of DLK1 transcripts in CLPG/CLPG animals
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observed. Lack of such effect would force us to re-
evaluate scenarios involving transcriptional regulation.
More work will be needed to gain a full understanding
of the molecular mechanisms underlying the trans-in-
hibition of DLK1, which is key element of polar over-
dominance at the CLPG locus.
Conclusions
Contrary to that of PEG11, the trans-inhibition of DLK1
that is observed in CLPG/CLPG sheep and lies at the
heart of polar overdominance, may not depend on post-




All animal procedures were carried out in strict accord-
ance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of Utah State Uni-
versity and approved by the Animal Ethics Committees
of Utah State University (IACUC #386).
RACE
The 5’ and 3’ ends of DLK1 transcripts were determined
using the GeneRacer Kit (Invitrogen, Carlsbad, CA) ac-
cording to the manufacturer’s instructions. Briefly, total
RNA was isolated either from skeletal muscle (longissi-
mus dorsi) of 2-week-old sheep of the four possible
CLPG genotypes (+/+, +Mat/CLPGPat, CLPGMat/+Pat,
CLPG/CLPG), or from COS1 cells 24 hrs after transfec-
tion with the ovine DLK1 expressing p3.1M-DLK1-HA
vector. For 5’ RACE, 3 μg of total RNA was used for
ligation of the GeneRacer RNA Oligo to the 5’ end of
RNA with a 5’ cap structure. RNA was then reverse tran-
scribed using SuperScript III reverse transcriptase using
random hexamers. For 3’ RACE, cDNA was synthesized
using the GeneRacer Oligo dT primer. These cDNAs
were then amplified with the GeneRacer 5’ and DLK1-
specific 5’ GSP-A primers for 5’ RACE, and the GeneRa-
cer 3’ and DLK1-specific 3’ GSP-S primers for 3’ RACE,
respectively. Nested PCR amplifications were performed
using diluted PCR products with the GeneRacer 5’
nested and DLK1-specific 5’ NGSP-A primers for 5’
RACE, and the GeneRacer 3’ nested and DLK1-specific
3’ NGSP-S primers for 3’ RACE, respectively. For both 5’
RACE PCRs, we used the Expand Long Template PCR
System (Roche Diagnostics, Basel, Switzerland) with
PCR conditions: 94°C for 2 min; 10 cycles of 94°C for 10
sec, 62°C for 30 sec and 68°C for 1 min; 22 cycles of
94°C for 15 sec, 62°C for 30 sec and 68°C for 1 min; and
68°C for 7 min. We used the Phusion DNA polymerase
(Finnzymes, Espoo, Finland) for the 3’ RACE PCRs using
touchdown PCR condition: 98°C for 30 sec; 8 cycles of98°C for 15 sec, 66°C for 20 sec and 72°C for 40 sec; 20
cycles of 98°C for 15 sec, 62°C for 20 sec and 72°C for
40 sec; and 72°C for 3 min. The nested PCR products
were analyzed by agarose gel electrophoresis, purified
from the gel, and sequenced either directly or after
subcloning in the pCR2.1 TA cloning vector (Invitrogen)
to determine the 5’ and 3’ ends of the DLK1 transcripts.
All primer sequences are listed in Additional file 2:
Table S3.
Generation of the p3.1M-DLK1-HA DLK1 expression vector
The ovine DLK1 ORF (C2 isoform) was PCR-amplified
using ovine skeletal muscle cDNA with primers p3.1-CS
and p3.1-CA containing XbaI and XhoI sites at their 5’
ends, respectively. The reverse primer (p3.1-CA)
included a HA tag sequence (AGCGTAGTCTGGG
ACGTCGTATGGGTA) to add the HA epitope at the
carboxyterminus of ovine DLK1 protein. The XbaI/XhoI
double-digested PCR fragment was cloned into the
XbaI/XhoI sites of the pcDNA3.1(-) mammalian expres-
sion vector (Invitrogen) to create an intermediate vector
p3.1-DLK1-CDS-HA. The 5’ UTR and a part of the cod-
ing sequence of ovine DLK1 was amplified from gen-
omic DNA using the Expand Long Template PCR
system with primers p3.1-5S containing an XbaI site at
the 5’ end and p3.1-5A encompassing an endogenous
NcoI site in the middle of the primer. The ovine DLK1 3’
UTR was PCR-amplified using genomic DNA with
primers, p3.1-3S and p3.1-3A containing XhoI and EcoRI
sites at their 5’ ends, respectively. The two resultant
PCR fragments were double-digested with XbaI/NcoI
and XhoI/EcoRI, respectively, and inserted sequentially
into the p3.1-DLK1-CDS-HA vector at the correspond-
ing sites to generate the p3.1-DLK1-FL-HA vector. To
minimize vector sequence in the transcripts (more spe-
cifically the multiple cloning region between the tran-
scription start and end sites of the vector), we modified
the original pcDNA3.1(-) vector (referred to as p3.1M).
We introduced an XbaI recognition site adjacent to the
putative transcriptional start site and an EcoRI site up-
stream of the bovine growth hormone polyadenylation
signal of the vector using the Quickchange lightening
site-directed mutagenesis kit (Stratagene, La Jolla, CA)
with oligonucleotides pc3.1-XbaI-intro-U/D and pc3.1-
EcoRI-intro-U/D, respectively. The insert of the p3.1-
DLK1-FL-HA (containing the HA tagged full-length of
ovine DLK1) was excised by an XbaI/EcoRI double-
digestion and transferred to the modified p3.1M vector
at the corresponding sites to generate the final p3.1M-
DLK1-HA vector. Orientation and integrity of the 1,405-
bp insert was confirmed by sequencing using the BigDye
Terminator v3.1 Cycle Sequencing kits and the 3730
DNA Analyzer (Applied Biosystems, Foster City, CA) in
three sequencing reactions using primers, Seq-S, Seq-A,
Cheng et al. BMC Genomics 2014, 15:944 Page 6 of 9
http://www.biomedcentral.com/1471-2164/15/944and 3’ NGSP-S. Primer information is available in
Additional file 2: Table S3.
Mimic miRNAs – choice of the system
To co-express miRNAs from the DLK1-GTL2 domain
with the vector expressing DLK1, we initially elected to
clone the corresponding miRNA precursors in expres-
sion vectors and co-transfect them. The hope was that
one vector would allow for the expression of multiple
miRNA species and isomirs (one miRNA precursor can
give rise to two miRNA “species” (from the 5p and 3p
arms, respectively), that can each come in multiple
forms or “isomirs”), and that this would optimally mimic
the condition prevailing in vivo at minimum cost. We
realized, however, that the expression levels of the dif-
ferent miRNA species varied enormously, without
necessarily mimicking the in vivo ratios [10], at concen-
trations that would often be <1% of endogenous let7d
levels (data not shown). As this would make compari-
sons between miRNAs nearly impossible, we opted for
the use of synthetic “mimic” miRNAs.
Mimic miRNAs – molecular design
We evaluated the efficacy of different designs of mimic
miRNAs using the luciferase assay described in Takeda
et al. [17] (see Additional file 1: Figure S10). It is based
on the pRL-4xTex and pRL-4xRom vectors, that each
contains four tandem repeats respectively with and with-
out miR-1 target sites. We compared four types of
mimic miRNAs: (i) an unmodified RNA duplex corre-
sponding to the endogenous mature and star ovine miR-
1 miRNAs (hence with bulge, wobble base pairs and
mismatch), (ii) an unmodified RNA duplex correspond-
ing to the mature ovine miR-1 and its perfect reverse
complement, with 2-nt 3’ overhangs at both ends (UU
for the passenger strand), (iii) the same as in (ii) but with
modified 5’ ends aimed at promoting the incorporation
of the guide strand into the RISC complex: 5’ P (phos-
phate) for the mature miRNA strand and/or 5’ NH2 for
the passenger strand, and (iv) the proprietary miR-1
miRNA Precursor purchased from Ambion. While type
(i) (i.e. a copy of the endogenous double-stranded
miRNA) did not have any effect, types (ii), (iii) and (iv)
worked equally well. We opted for type (ii) with un-
modified mature strand and 5’ NH2 modified passenger
strand. The 3’ overhangs for all passenger strands corre-
sponded to UU dinucleotides. Corresponding oligonu-
cleotides were purchased from GenePharma (Shanghai,
China).
Mimic miRNAs – sequence determination
To select representative mimic miRNA sequences for all
miRNAs from the DLK1-GTL2 domain, we simul-
taneously utilized (i) previously generated RNA-Seqinformation that was used to establish a catalogue of
miRNAs expressed in ovine skeletal muscle with special
emphasis on the DLK1-GTL2 domain [10], (ii) miRNA
characteristics inferred from meta-analyses of mouse
and Drosophila melanogaster small RNAs [25,26], and
(iii) information of human, mouse, and bovine orthologs
from miRBase [27]. In most cases, the selected se-
quences corresponded to the most abundant isomirs in
the ovine RNA-Seq data, matching the miRBase regis-
tered sequences, and formed a canonical mature and star
miRNA duplex with 3’ overhangs. To those, we added (i)
“star” sequences that were not registered in the miRBase
but were observed in our RNA-Seq data, and (ii) alterna-
tive isomir with 5’ heterogeneity that represented more
than one third of the reads of a corresponding miRBase-
registered miRNA or with more than 200 reads in any of
the RNA-Seq libraries. A-to-I editing [10] or untem-
plated nucleotide addition (data not shown) were ob-
served in some of miRNAs from the DLK1-GTL2
domain. This was accounted for by synthesizing isomirs
with mixed bases at the corresponding sites. The
complete list of 121 tested mimic miRNAs is provided
in Additional file 2: Table S1. MiRNAs derived from the
5p and 3p arms of a miRNA hairpin precursor are suf-
fixed with -5p and -3p, respectively, irrespective of their
relative expression levels.
To design negative control miRNA, we first shuffled
sequences of five miRNAs (oar-miR-433-3p, 127-3p,
3957-3p, 377-3p, and 376c-3p) ten times each. We then
counted the number of 8-mer, 7mer-A1, 7mer-m8, and
6-mer seed matches [15] of these shuffled sequences to
the full-length ovine DLK1 C2 isoform. In addition, to
minimize off-target effects on unintended endogenous
RNAs, we predicted the number of genome wide con-
served miRNA target sites across most mammals using
the TargetScan Custom software [28,29]. Two of the
shuffled sequences that showed neither 6-, 7- nor 8-mer
seed matches to the ovine DLK1 and the lowest number
of predicted genome-wide conserved target sites (seven
and one conserved targets, respectively) were selected as
negative controls (designated as Scr-oar-miR-127-3p
(NC1) and Scr-oar-miR-377-3p (NC2)). In addition, we
purchased one siRNA targeting the ovine DLK1 ORF by
using the BLOCK-iT RNAi Designer (Invitrogen), to be
used as positive control.
Cell culture and transient transfection
COS1 cells were cultured in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal bovine serum and
0.1 mM non-essential amino acids, 100 units/ml peni-
cillin and 100 mg/ml streptomycin at 37°C (GIBCO,
Renfrewshire, UK). One day before transfection, 0.5 ×
105 cells were seeded in a 12-well plate in 800 μl of
growth medium without antibiotics. We then co-
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(GIBCO) containing 200 ng of the p3.1M-DLK1-HA vec-
tor, 400 ng of pcDNA3-GFP vector (Plasmid ID: 13031
obtained from Addgene, Cambridge, MA) along with 40
pmols of synthetic mimic miRNA (GenePharma)(final
concentration 40 nM) or 5 pmols of siRNA (Invitrogen)
using 4 μl of Lipofectamin 2000 (Invitrogen) according to
the manufacturer’s instructions.
Dual fluorescence Western blotting
Total protein was extracted from COS1 cells 24 hrs after
transfection using a modified RIPA buffer containing 50
mM Tris-HCl (pH 7.6), 150 mM NaCl, 1% Igepal CA-
630, 0.25% sodium deoxycholate, 1 mM EDTA and the
complete protease inhibitor cocktail (Roche). The lysate
was centrifuged at 12,000 × g for 15 min at 4°C and pro-
tein concentration of the supernatant was determined
using the micro BCA Protein Assay Kit (Pierce, Rock-
ford, IL) according to the manufacturer's instructions.
Eight μg of protein were boiled for 5 min in Laemmli
buffer (62.5 mM Tris-HCl (pH 7.6), 2% sodium dodecyl
sulfate (SDS), 10% glycerol, 0.004% bromophenol blue,
5% β-mercaptoethanol) and loaded on a NuPAGE Novex
4-12% Bis-Tris Midi gel (Invitrogen). Electrophoresis
was performed with the XCell4 SureLock Midi-Cell elec-
trophoresis chamber (Invitrogen) at 200 V for 30 min at
room temperature in the NuPAGE MOPS SDS Running
buffer (Invitrogen). Protein was then transferred to a
Hybond-LFP Polyvinylidene difluoride (PVDF) mem-
brane (GE Healthcare, Buckinghamshire, UK) at 200 mA
for 90 min at 4°C using the NuPAGE transfer buffer
(Invitrogen) in a Criterion Blotter (BioRad, Hercules,
CA). The membrane was blocked with 10% non-fat dry
milk in PBST buffer (1 mM KH2PO4, 10 mM Na2HPO4,
137 mM NaCl, 2.7 mM KCl, 0.1% Tween 20) either at
room temperature for 1 hr or at 4°C overnight. The
membrane was incubated sequentially with a series of
antibodies diluted in the blocking buffer at room
temperature for 1 hr. We used a rabbit polyclonal anti-
HA tag antibody (1:4000 dilution) (ab9110, Abcam,
Cambridge, UK), an ECL Plex anti-rabbit IgG antibody
conjugated with Cy5 dye (1:2500) (PA45011, GE Health-
care), a mouse monoclonal anti-GFP antibody (1:1000)
(clone JL-8, Clontech Laboratories, Mountain View,
CA), a mouse monoclonal anti-α-Tubulin antibody
(1:8000) (T6074, Sigma, St. Louis, MO), and an ECL
Plex anti-mouse IgG antibody conjugated with Cy3 dye
(1:4000) (PA43010, GE Healthcare). Membranes were
washed three times for 10 min in PBST buffer with gen-
tle shaking between incubations. The membrane was
then dried at 37°C for 1 hr, followed by scanning with
the Typhoon 9400 scanner (GE healthcare). Band inten-
sities corresponding to HA-tagged DLK1, GFP, and
Tubulin were quantified using the ImageQuant TLsoftware (GE healthcare). For normalization, the band
intensities were first divided by the corresponding
membrane-specific averages (not including siRNA),
yielding “relative” DLK1, GFP, Tubulin amounts. The
relative DLK1 amounts were then divided by either the
corresponding relative GFP or Tubulin amounts, yield-
ing “corrected” DLK1 amounts. We performed more
than four independent transfections of cells for each
mimic miRNA, and ran more than two independent
Western blot experiments per transfection. MiRNA ef-
fect on the DLK1 expression was estimated by compar-
ing the mean of the corrected DLK1 amounts for a
given miRNA either to the global mean (not including
siRNA data) or to the average of NC1 and NC2 data.
Deglycosylation
As DLK1 has been reported to be N- and O-glycosylated
[30], we carried out Western blot analysis using proteins
treated with the Protein Deglycosylation mix (New
England Biolabs, Ipswich, MA) according to the manu-
facturer’s instructions. Briefly, COS1 cells transfected
with the p3.1M-DLK1-HA vector were harvested in the
Phosphate Buffered Saline (GIBCO) supplied with 1%
Igepal CA-630 and the complete protease inhibitor
cocktail. Twenty μg of protein were denatured at 99°C
for 10 min and treated at 37°C for 4 hrs with a mixture
of deglycosylation enzymes that were expected to re-
move all N-linked and simple O-linked glycans, as well
as some complex O-linked glycans. Western blot was
performed as described above.
Northern blot analysis
Total RNA was isolated from COS1 cells 24 hrs after
transfection with the p3.1M-DLK1-HA vector using the
Trizol reagent (Invitrogen) according to the manufac-
turer’s protocol. Ten μg of total RNA was denatured at
50°C for 10 min in 20 μl of 1 × MOPS buffer (20 mM 3-
(N-morpholino) propanesulfonic acid, 5 mM sodium
acetate, 1 mM EDTA, 1 mM EGTA, pH 7.0) supplied
with 2.4 M formaldehyde and 50% formamide. The RNA
was mixed with loading buffer (final 5% glycerol, 0.025%
bromophenol blue, 0.025% xylene cyanol) and subjected
to electrophoresis on a 1% agarose gel containing 1.75
M formaldehyde in 1 × MOPS buffer at 5 V/cm for 3.5
hrs. After electrophoresis, the RNA was transferred onto
a Hybond-N+ nylon membrane (GE Healthcare) with
10 × SSC buffer (150 mM sodium citrate, 1.5 M NaCl,
pH 7.0) and UV cross-linked essentially as described in
Sambrook et al. [31]. A DNA fragment containing the
ovine DLK1 ORF region (857-bp) was gel-purified after
digesting the plasmid p3.1M-DLK1-HA with NcoI and
BglII and labeled with [α-32P] dCTP (GE Healthcare)
using the Prime-It II random primer labeling kit (Stra-
tagene). The membrane was pre-hybridized with the
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hybridized with 1 × 106 cpm/ml of the 32P-labeled probe
at 45°C overnight. Membranes were washed twice at
55°C for 20 min in 2 × SSC and 0.1% SDS, then twice at
55°C for 30 min in 0.1 × SSC and 0.1% SDS. Membranes
were exposed to the Hyperfilm ECL film (GE Health-
care) for 3 hrs.Generation of ovine GTL2 expression vector
Ovine GTL2 sequence (see Additional file 1: Text S2)
was PCR-amplified from cDNA synthesized with ran-
dom hexamers from longissimus dorsi skeletal muscle
RNA of an 8-week-old CLPG/CLPG animal using the
Phusion DNA polymerase with primers, ovGTL2-FL-S1
and ovGTL2-FL-A1 (see Additional file 2: Table S3).
The resultant PCR product was sub-cloned into the
pCRII-blunt-TOPO vector (Invitrogen) and subjected to
DNA sequencing for confirmation. The insert was ex-
cised with EcoRI and ligated into the corresponding site
of the pcDNA3.1(-) vector to produce the p3.1-GTL2
and p3.1-antiGTL2 vectors that express ovine GTL2 in
sense and antisense orientations, respectively. Integrity
of the insert was confirmed by sequencing.In silico affinity score of miRNA to DLK1
Affinity scores of each miRNA for ovine DLK1 transcript
expressed from the p3.1M-DLK1-HA were computed
using Miranda [16] and a seed-based score [15]. Miranda
scores were obtained by running the Miranda v3.3a soft-
ware using the miRNA sequences (see Additional file 2:
Table S1) and the ovine DLK1 5’ UTR, ORF, 3’ UTR,
and full-length sequences (see Additional file 1: Text
S1). For the Grimson seed match score, we simply
counted the number of sites complementary to miRNA
seed sequences (8mer, 7mer-A1, 7mer-m8, 6mer, and
6mer-offset seed matches [15]) on the DLK1 sequences.
Pearson correlation coefficients between the prediction
scores and the corrected DLK1 amounts (DLK1/GFP)
(without controls) and its significant levels were calcu-
lated using standard procedures.Additional files
Additional file 1: Figure S1. Working model for polar overdominance
at the ovine callipyge locus [11]. Figure S2: Characterization of the 5’ and
3’ ends of ovine DLK1 transcripts in ovine skeletal muscle. Figure S3:
Construction and characterization of the p3.1M-DLK1-HA vector
expressing full length ovine DLK1 [30]. Figure S4: Quantitativeness of
Western blot analysis of ovine DLK1 protein. Figure S5: Dual fluorescent
Western blot to measure DLK1 amount. Figure S6: Conservation around
oar-miR-329a-3p 6-mer seed matches on DLK1 [15,32]. Figure S7: Weak
correlation between miRNA-target affinity score and DLK1 [15,16]. Figure
S8: MiRNAs used for a multiple-miRNA transfection test. Figure S9: Effect
of GTL2 lncRNA expression on DLK1 amount. Figure S10: Functionality of
synthetic mimic miRNAs [17]. Text S1: RNA sequence transcribed fromthe p3.1M-DLK1-HA expression vector. Text S2: Ovine GTL2 sequence in
the p3.1-GTL2 expression vector.
Additional file 2: Table S1. Mimic miRNA sequence information [10,33].
Table S2: Effect of each mimic miRNA on DLK1 expression and its
correlation with predicted affinity scores [15,16]. Table S3: Oligonucleotides
used in this study.
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